Skip to main content
University of California San Francisco
UCSF  |  
About UCSF   |   Search UCSF
Home
Technology Disclosure
  • Services
    • HealthTech Commercialization
    • Innovation & Entrepreneurship
    • Funding for Translational Technology
  • Teams
    • Engagement & Opportunity Development
    • Technology Licensing
    • Strategic Alliances
    • Business Affairs & Strategic Partnerships
    • Catalyst
  • Resources
    • Policies
    • Forms
    • Outgoing Material Transfer
    • Industry Statistics
    • Startup Resources
    • Translational Opportunities
    • Jobs & Internships
    • Partnering with Industry FAQs
    • Protecting Your Idea
    • Technology Disclosure
  • About
    • Events
    • Contact
    • Success Stories
    • Featured Startups
    • Teams
  • Media
    • News
    • Newsletters
    • Podcasts
    • Videos
  • linkedin
  • vimeo
  • youtube
Skip to main content
  • Home
  • Media

UCSF Innovation News

UCSF's latest innovations in healthcare & technology

NEWS


UCSF Speakers Reach Record Numbers at 2023 Precision Medicine World Conference
UCSF Speakers Reach Record Numbers at 2023 Precision Medicine World Conference 03/29/2023
ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform
ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform 03/29/2023
EpiBiologics Launches with $50 million to Advance Next-Generation Protein Degradation Platform
EpiBiologics Launches with $50 million to Advance Next-Generation Protein Degradation Platform 03/23/2023
MindRhythm's EPISODE-PS Initial Trial Results are Published
MindRhythm's EPISODE-PS Initial Trial Results are Published 03/16/2023
Thymmune Secures $7M in Seed Financing to Develop Thymus Cell Therapy Platform for Immune System Renewal
Thymmune Secures $7M in Seed Financing to Develop Thymus Cell Therapy Platform for Immune System Renewal 03/06/2023
Nested Therapeutics Announces Nomination of First Development Candidate, a Potential First-in-Class Inhibitor of the RAS/MAPK Pathway
Nested Therapeutics Announces Nomination of First Development Candidate, a Potential First-in-Class Inhibitor of the RAS/MAPK Pathway 03/02/2023
Chroma Medicine Secures $135M in Series B Financing
Chroma Medicine Secures $135M in Series B Financing 03/01/2023
MindRhythm Initiates Pivotal Portion of Prehospital Stroke Trial
MindRhythm Initiates Pivotal Portion of Prehospital Stroke Trial 02/15/2023
The University of California and Foundery Sign Master Agreement to Translate Novel Discoveries into Transformational Immunotherapies
The University of California and Foundery Sign Master Agreement to Translate Novel Discoveries into Transformational Immunotherapies 02/09/2023
Long-term functional regeneration of radiation-damaged salivary glands through delivery of a neurogenic hydrogel
Long-term functional regeneration of radiation-damaged salivary glands through delivery of a neurogenic hydrogel 02/02/2023
Barry Selick Moves From UCSF To Hinge Bio
Barry Selick Moves From UCSF To Hinge Bio 01/31/2023
Rezo Therapeutics to Emerge from Stealth
Rezo Therapeutics to Emerge from Stealth 01/27/2023
Increasing the success potential of promising biotech companies
Increasing the success potential of promising biotech companies 01/19/2023
Catalyst Awardees Present to Investors at the “Born in California Investor Demo Days”
Catalyst Awardees Present to Investors at the “Born in California Investor Demo Days” 01/12/2023
ArsenalBio Announces First Patient Dosed in Phase 1 Clinical Trial in Treatment for Ovarian Cancer
ArsenalBio Announces First Patient Dosed in Phase 1 Clinical Trial in Treatment for Ovarian Cancer 01/06/2023
  • Previous page ‹‹ Prev
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Current page 12
  • Page 13
  • Page 14
  • Next page ›› Next
  • About
    • Events
    • Contact
    • Featured Startups
    • Success Stories
    • Teams
  • Teams
    • Engagement & Opportunity Development
    • Technology Licensing
    • Strategic Alliances
    • Business Affairs & Strategic Partnerships
    • Catalyst
  • Services
    • HealthTech Commercialization
    • Innovation & Entrepreneurship
    • Funding
    • Catalyst Program
  • Partnerships
    • Finding an Industry Partner
    • Establishing Research Collaborations
    • Panther Program
    • Precision Medicine
    • QB3
    • UCSF Health
  • Resources
    • Innovation Showcase
    • Translational Opportunities
    • Forms
    • Outgoing Material Transfer
    • Policies
    • Startup Resources
    • Partnering with Industry FAQs
    • Leadership Dashboard
    • Protecting Your Idea
    • Technology Disclosure

RECENT NEWS

  • United Therapeutics Corporation Acquires Thymmune Therapeutics
  • UCSF Innovation Translates Discovery into Life-Saving Diagnostics
  • Inventor of Crispr is skeptical about AI

Contact

  • Email:  [email protected]
  • UCSF Wayne and Gladys Valley Center
    490 Illinois Street, North Tower, 400-A
    San Francisco, CA 94143
  • Campus Mail: PO box: 2142
  • linkedin
  • vimeo
  • youtube
2026 ©  The Regents of the University of California
  • Accessibility
  • Usage
  • Privacy